Intellia Therapeutics Inc sell geldnutzer
Start price
25.12.25
/
60%
€7.90
Target price
25.12.26
€6.00
Performance (%)
36.23%
Price
16.01.26
€10.77
Summary
This prediction is currently active. The price for Intellia Therapeutics Inc has massively increased, which is bad news for the SELL prediction by geldnutzer. This prediction currently runs until 25.12.26. The prediction end date can be changed by geldnutzer at any time. geldnutzer has 60% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | 20.603% |
| iShares Core DAX® | 0.191% |
| iShares Nasdaq 100 | -0.614% |
| iShares Nikkei 225® | 0.599% |
| iShares S&P 500 | -0.036% |
According to geldnutzer what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Below average Management
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Growths slower than the competition
high free float
Below average Marketposition
Significant cyclical dependencies
Unknown brand
Business model of the past or high risk
Sustainability is not important
Higher risks for its business